imipramine hydrochloride

Generic: imipramine hydrochloride

Labeler: lupin pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name imipramine hydrochloride
Generic Name imipramine hydrochloride
Labeler lupin pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

imipramine hydrochloride 50 mg/1

Manufacturer
Lupin Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68180-313
Product ID 68180-313_b891d3a3-3346-441e-99cc-03528b4afa46
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090441
Listing Expiration 2026-12-31
Marketing Start 2010-12-21

Pharmacologic Class

Classes
tricyclic antidepressant [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68180313
Hyphenated Format 68180-313

Supplemental Identifiers

RxCUI
835564 835568 835593
UNII
BKE5Q1J60U

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name imipramine hydrochloride (source: ndc)
Generic Name imipramine hydrochloride (source: ndc)
Application Number ANDA090441 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • HOW SUPPLIED Imipramine hydrochloride tablets USP, containing 10 mg imipramine hydrochloride, are round, biconvex, yellow film-coated tablets debossed with "LU" on one side and "V11" on the other side. They are supplied as follows: NDC 68180-311-01 Bottles of 100's NDC 68180-311-02 Bottles of 500's Imipramine hydrochloride tablets USP, containing 25 mg imipramine hydrochloride, are round, biconvex, green film-coated tablets debossed with "LU" on one side and "V12" on the other side. They are supplied as follows: NDC 68180-312-01 Bottles of 100's NDC 68180-312-02 Bottles of 500's Imipramine hydrochloride tablets USP, containing 50 mg imipramine hydrochloride, are round, biconvex, reddish brown film-coated tablets debossed with "LU" on one side and "V13" on the other side. They are supplied as follows: NDC 68180-313-01 Bottles of 100's NDC 68180-313-02 Bottles of 500's Store at 25°C (77°F); excursions permitted to 15°-30°C (59°- 86°F) [see USP Controlled Room Temperature]. Preserve in well-closed containers. Dispense in tight container (USP) with a child-resistant closure. ANIMAL PHARMACOLOGY & TOXICOLOGY A. Acute: Oral LD 50 ranges are as follows: Rat 355 to 682 mg/kg Dog 100 to 215 mg/kg Depending on the dosage in both species, toxic signs proceeded progressively from depression, irregular respiration and ataxia to convulsions and death. B. Reproduction/Teratogenic: The overall evaluation may be summed up in the following manner: Oral: Independent studies in three species (rat, mouse, and rabbit) revealed that when imipramine hydrochloride is administered orally in doses up to approximately 2-1/2 times the maximum human dose in the first 2 species and up to 25 times the maximum human dose in the third species, the drug is essentially free from teratogenic potential. In the three species studied, only one instance of fetal abnormality occurred (in the rabbit) and in that study there was likewise an abnormality in the control group. However, evidence does exist from the rat studies that some systemic and embryotoxic potential is demonstrable. This is manifested by reduced litter size, a slight increase in the stillborn rate, and a reduction in the mean birth weight.
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Imipramine Hydrochloride Tablets 10 mg – Bottle of 100s NDC 68180-311-01 bottles of 100s Imipramine Hydrochloride Tablets 25 mg – Bottle of 100s NDC 68180-312-01 bottles of 100s Imipramine Hydrochloride Tablets 50 mg – Bottle of 100s NDC 68180-313-01 bottles of 100s imi-10-100 imi-25-100 imi-50-100
source: label

Packages (0)

No package records.

Ingredients (1)

imipramine hydrochloride (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b891d3a3-3346-441e-99cc-03528b4afa46", "openfda": {"unii": ["BKE5Q1J60U"], "rxcui": ["835564", "835568", "835593"], "spl_set_id": ["55311747-710c-43c4-821d-76323ff2520e"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Imipramine Hydrochloride", "product_id": "68180-313_b891d3a3-3346-441e-99cc-03528b4afa46", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Tricyclic Antidepressant [EPC]"], "product_ndc": "68180-313", "generic_name": "Imipramine Hydrochloride", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Imipramine Hydrochloride", "active_ingredients": [{"name": "IMIPRAMINE HYDROCHLORIDE", "strength": "50 mg/1"}], "application_number": "ANDA090441", "marketing_category": "ANDA", "marketing_start_date": "20101221", "listing_expiration_date": "20261231"}